Ultragenyx Pharmaceutical Inc.
RARE
$39.34
$0.090.23%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.69% | 37.42% | 38.38% | -34.52% | -22.81% |
| Total Receivables | 65.93% | 19.38% | 48.69% | 80.38% | 59.01% |
| Inventory | 32.49% | 36.26% | 42.05% | 34.91% | 26.91% |
| Prepaid Expenses | -28.81% | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 238.94% | 2,615.84% | 2,989.62% | 2,319.91% | -96.79% |
| Total Current Assets | 11.60% | 33.45% | 37.39% | -22.23% | -17.16% |
|
|
|||||
| Total Current Assets | 11.60% | 33.45% | 37.39% | -22.23% | -17.16% |
| Net Property, Plant & Equipment | -7.33% | -15.71% | -9.57% | -5.22% | 10.06% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 7.24% | 4.86% | 5.06% | 3.69% | 3.85% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 10.05% | 93.12% | 103.00% | 169.42% | 51.24% |
| Total Assets | 0.83% | 24.25% | 23.42% | -5.52% | -3.52% |
|
|
|||||
| Total Accounts Payable | -7.97% | 7.89% | 42.01% | -30.53% | -2.68% |
| Total Accrued Expenses | 22.64% | 3.59% | -7.89% | 3.27% | -4.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 43.76% | 40.85% | 69.43% | 274.95% | 255.18% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 22.72% | 12.22% | 11.66% | 12.56% | 7.36% |
|
|
|||||
| Total Current Liabilities | 22.72% | 12.22% | 11.66% | 12.56% | 7.36% |
| Long-Term Debt | -4.93% | -5.29% | -4.41% | -4.26% | -1.50% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.74% | -31.54% | 73.40% | 61.36% | 54.31% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 11.54% | 10.23% | 7.60% | 8.83% | 15.83% |
| Total Liabilities | 2.10% | -1.81% | 0.32% | 0.33% | 1.90% |
|
|
|||||
| Common Stock & APIC | 15.03% | 26.41% | 27.39% | 16.71% | 16.63% |
| Retained Earnings | -16.80% | -17.12% | -18.85% | -20.83% | -21.81% |
| Treasury Stock & Other | -199.38% | 139.93% | 64.65% | 89.14% | 109.84% |
| Total Common Equity | -7.30% | 993.61% | 235.13% | -36.38% | -21.87% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -7.30% | 993.61% | 235.13% | -36.38% | -21.87% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.76% | 1,015.68% | 235.13% | -36.38% | -21.87% |
|
|
|||||
